0001225208-20-013697.txt : 20201119 0001225208-20-013697.hdr.sgml : 20201119 20201119175501 ACCESSION NUMBER: 0001225208-20-013697 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201117 FILED AS OF DATE: 20201119 DATE AS OF CHANGE: 20201119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wallace Noel R. CENTRAL INDEX KEY: 0001464265 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-00644 FILM NUMBER: 201329874 MAIL ADDRESS: STREET 1: C/O COLGATE-PALMOLIVE COMPANY STREET 2: 300 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COLGATE PALMOLIVE CO CENTRAL INDEX KEY: 0000021665 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] IRS NUMBER: 131815595 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2123102000 MAIL ADDRESS: STREET 1: 300 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10022 4 1 doc4.xml X0306 4 2020-11-17 0000021665 COLGATE PALMOLIVE CO CL 0001464265 Wallace Noel R. C/O COLGATE-PALMOLIVE COMPANY 300 PARK AVENUE NEW YORK NY 10022 1 1 Chairman, President & CEO Common Stock 2020-11-17 4 M 0 25000.0000 61.9300 A 227840.0000 D Common Stock 2020-11-17 4 S 0 21446.0000 85.8573 D 206394.0000 D Common Stock 47684.0000 I By Issuer's 401(k) Plan Trustee Common Stock 335.0000 I By Trust Stock Option (Right to Buy) 61.9300 2020-11-17 4 M 0 25000.0000 0.0000 D 2021-09-10 Common Stock 25000.0000 25279.0000 D Exercise of stock options awarded under the issuer's incentive compensation plan. Sale of shares with proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. Weighted average price, as these shares were sold in multiple transactions at prices ranging from $85.71 to $86.02, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2015 grant date. /s/ Kristine Hutchinson, Attorney-in-Fact 2020-11-19